RG108 (GMP) is RG108 (HY-13642) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. RG108 (N-Phthalyl-L-tryptophan) is a non-nucleoside DNA methyltransferases (DNMTs) inhibitor (IC50=115 nM) that blocks the DNMTs active site. RG108 (N-Phthalyl-L-tryptophan) causes demethylation and reactivation of tumor suppressor genes, but it does not affect the methylation of centromeric satellite sequences.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 48208-26-0
- Formule: C19H14N2O4
- Masse moléculaire:334.33
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
-
HY-13642
RG108DNMT Inhibitor -
HY-A0004
DecitabineDNMT Inhibitor -
HY-10586
5-AzacytidineDNMT Inhibitor -
HY-A0004R
Decitabine (Standard)DNMT Inhibitor -
HY-10586R
5-Azacytidine (Standard)DNMT Inhibitor -
HY-13420
ZebularineDNA Methylation Inhibitor -
HY-13668
LomeguatribMGMT Inhibitor -
HY-139664
GSK-3685032DNMT1 Inhibitor -
HY-12746
DC-05DNA Methyltransferase Inhibitor -
HY-13765
6-ThioguanineImmunosuppressant Agent -
HY-13962
SGI-1027Apoptosis Inducer -
HY-B2194
γ-OryzanolDNA Methyltransferase Inhibitor
Voir tous les produits spécifiques à Isoform DNA Methyltransferase
More
Activité biologique
Description
IC50 & Target
[1]|
CpG methylase M.SssI 115 nM (IC50) |
In Vitro
RG108 (GMP) effectively blocks DNA methyltransferases in vitro and does not cause covalent enzyme trapping in human cell lines. Incubation of cells with low micromolar concentrations of RG108 (GMP) results in significant demethylation of genomic DNA without any detectable toxicity. Intriguingly, RG108 (GMP) causes demethylation and reactivation of tumor suppressor genes, but it does not affect the methylation of centromeric satellite sequences[1].
In another study, the synthesis and in vitro analysis of a biotinylated RG108 (GMP) conjugate is investigated to evaluate the interactions with DNA methyltransferase enzymes[2].
In a recent study, it is shown RG108 (GMP) can significantly reduce the DNA methyltransferases activity in SM derived iPS cells as compared to the native SMs[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 48208-26-0
-
Masse moléculaire 334.33
-
Formule C19H14N2O4
-
SMILES
O=C(N1[C@H](C(O)=O)CC2=CNC3=C2C=CC=C3)C4=CC=CC=C4C1=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Brueckner B, et al. Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res. 2005 Jul 15;65(14):6305-11. [Content Brief]
[2]. Schirrmacher E, et al. Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases. Bioconjug Chem. 2006 Mar-Apr;17(2):261-6. [Content Brief]
[3]. Pasha Z, et al. Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells. PLoS One. 2011;6(8):e23667. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
RG108 (GMP) Related Classifications
HY-13642G Related Classifications
Powered by Bioz